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Abstract
Efficient carbon assimilation is critical for microbial growth and pathogenesis. The environ-
mental yeast Saccharomyces cerevisiae is “Crabtree positive”, displaying a rapid metabolic
switch from the assimilation of alternative carbon sources to sugars. Following exposure to
sugars, this switch is mediated by the transcriptional repression of genes (carbon catabolite
repression) and the turnover (catabolite inactivation) of enzymes involved in the assimila-
tion of alternative carbon sources. The pathogenic yeast Candida albicans is Crabtree
negative. It has retained carbon catabolite repression mechanisms, but has undergone
posttranscriptional rewiring such that gluconeogenic and glyoxylate cycle enzymes are not
subject to ubiquitin-mediated catabolite inactivation. Consequently, when glucose becomes
available, C. albicans can continue to assimilate alternative carbon sources alongside the
glucose. We show that this metabolic flexibility promotes host colonization and virulence.
The glyoxylate cycle enzyme isocitrate lyase (CaIcl1) was rendered sensitive to ubiquitin-
mediated catabolite inactivation in C. albicans by addition of a ubiquitination site. This muta-
tion, which inhibits lactate assimilation in the presence of glucose, reduces the ability of C.
albicans cells to withstand macrophage killing, colonize the gastrointestinal tract and cause
systemic infections in mice. Interestingly, most S. cerevisiae clinical isolates we examined
(67%) have acquired the ability to assimilate lactate in the presence of glucose (i.e. they
have become Crabtree negative). These S. cerevisiae strains are more resistant to macro-
phage killing than Crabtree positive clinical isolates. Moreover, Crabtree negative S.
cerevisiaemutants that lack Gid8, a key component of the Glucose-Induced Degradation
complex, are more resistant to macrophage killing and display increased virulence in immu-
nocompromised mice. Thus, while Crabtree positivity might impart a fitness advantage for
yeasts in environmental niches, the more flexible carbon assimilation strategies offered by
Crabtree negativity enhance the ability of yeasts to colonize and infect the mammalian host.
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Author Summary
Most yeast species occupy environmental niches, but some infect humans. All species
must assimilate carbon to grow and colonize their niche, but carbon source availability dif-
fers significantly between niches. The environmental yeast Saccharomyces cerevisiae is
thought to have evolved under conditions of sugar feast and famine because it has evolved
mechanisms to exploit energetically favourable sugars first, and then switch to using alter-
native carbon sources. These mechanisms depend on catabolite inactivation—the degrada-
tion of enzymes involved in the assimilation of alternative carbon sources when glucose is
present. In the pathogenic yeast Candida albicans, which has evolved in sugar-poor host
niches, these enzymes are not subject to catabolite inactivation. Consequently, C. albicans
can simultaneously exploit sugars and alternative carbon sources. We demonstrate that
this metabolic flexibility promotes resistance to macrophage killing, gut colonization, and
the ability to cause systemic infection. We also show that many S. cerevisiae clinical isolates
have lost catabolite inactivation, and hence can simultaneously assimilate sugars and alter-
native carbon sources. The disruption of catabolite inactivation in S. cerevisiae renders it
more resistant to phagocytic killing, and more virulent. We conclude that virulence is
enhanced by metabolic flexibility.
Introduction
Microbes must acquire nutrients efficiently if they are to compete effectively in complex
microenvironments. A common microbial strategy is to focus resources on the utilization of
energetically favourable carbon sources when they are available, and then, once they become
exhausted, switch to alternative, less favourable carbon sources. For example, organisms such
as Escherichia coli and Saccharomyces cerevisiae assimilate sugars such as glucose before
switching to less favourable carbon sources such as alcohols and organic acids [1, 2]. This
behaviour reflects the niches these microbes occupy. In these environments, microbes often
compete for survival during cycles of “feast and famine”, where periods of growth on less
favourable carbon sources or starvation are punctuated by episodes of sugar availability [2].
These organisms have evolved elegant regulatory mechanisms, such as the lac operon [3] and
GAL regulon [4], that mediate the efficient, sequential assimilation of sugars and alternative
carbon sources. In contrast, microbes that have evolved in niches that contain limiting sugar
concentrations display alternative modes of carbon assimilation. For example, the fungal
pathogen Candida albicans is able to assimilate sugars and alternative carbon sources simulta-
neously [5]. We show here that this type of metabolic flexibility enhances the ability of yeasts
to colonise and infect the mammalian host.
S. cerevisiae is an environmental yeast that is thought to have evolved under conditions of
sugar “feast and famine” [2]. It is defined as a “Crabtree positive” yeast on the basis that glucose
represses respiratory metabolism even under aerobic conditions [6, 7]. Consequently, when S.
cerevisiae encounters mixtures of carbon sources, this yeast first assimilates glucose, converting
it to ethanol via fermentative metabolism. Then, once glucose is exhausted, S. cerevisiae dere-
presses metabolic pathways required for the assimilation of alternative carbon sources through
a combination of transcriptional and posttranscriptional regulatory mechanisms. Glucose trig-
gers the transcriptional repression of gluconeogenic and glyoxylate cycle genes (carbon catabo-
lite repression), and accelerates the degradation of gluconeogenic mRNAs [8, 9]. Glucose also
triggers the inactivation and degradation of gluconeogenic and glyoxylate cycle enzymes
(catabolite inactivation) (Fig 1) [10, 11]. This glucose-accelerated protein degradation is driven
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in part by the ubiquitination of target metabolic enzymes by the Glucose-Induced Degradation
(GID) complex (Fig 1) [12]. The GID complex is an E3 ubiquitin ligase composed of seven pro-
teins (Gid1/Vid30, Gid2/Rmd5, Gid4/Vid24, Gid5/Vid28, Gid7, Gid8, and Gid9/Fyv10), with
Gid8 being essential for the activity of this complex [13, 14]. Following exposure to glucose, the
GID complex recruits the ubiquitin-conjugating enzyme Ubc8 to target enzymes, leading to
their ubiquitination and subsequent degradation [15]. Targets for glucose-accelerated ubiqui-
tinmediated protein degradation in S. cerevisiae include the gluconeogenic enzymes Fbp1 and
Pck1, and the glyoxylate cycle enzyme Icl1 [16, 17]. Together, these mechanisms rapidly shut
down the assimilation of alternative carbon sources following glucose addition.
The S. cerevisiae paradigm has been extended to other yeasts. However, this S. cerevisiae-
centric perspective is challenged by the metabolic plasticity of other yeast species [5, 18–20]. C.
albicans is defined as a “Crabtree negative” yeast because it retains respiratory metabolism fol-
lowing glucose addition [5, 13]. However, at the transcriptional level, this pathogenic yeast is as
sensitive to glucose as its distant relative, S. cerevisiae [18, 21, 22]. C. albicans responds to very
low sugar concentrations, displaying significant downregulation of gluconeogenic and glyoxy-
late cycle genes following exposure to 0.01% glucose [18, 21, 22]. Yet C. albicans cells continue
to assimilate alternative carbon sources following glucose addition [18]. This is because gluco-
neogenic and glyoxylate cycle enzymes are retained following glucose addition, and are not
subject to catabolite inactivation (Fig 1) [18]. Key enzymes, such as isocitrate lyase (CaIcl1),
lack the ubiquitination sites that target their S. cerevisiae orthologues for glucose-accelerated
ubiquitin-mediated protein degradation. As a result, when sugars become available, C. albicans
can continue to assimilate alternative carbon sources simultaneously with these sugars [18].
Therefore, catabolite inactivation plays a key role in the management of carbon utilization.
C. albicans is capable of colonizing a diverse range of complex niches in its mammalian
host. This yeast colonizes the oral cavity, the gastrointestinal tract and genitalia in many indi-
viduals, is a frequent cause of mucosal infection (oral thrush and vaginitis), and in severely
immunocompromised patients can cause life-threatening systemic infections [23, 24]. In these
niches C. albicans is exposed to complex mixtures of carbon sources that include amino acids,
fatty acids, and carboxylic acids, such as lactate. Some niches contain relatively low levels of
glucose, at least compared to the 2% glucose often used to cultivate C. albicans in vitro. The
bloodstream contains 4 to 7 mM (0.07–0.13%) glucose, whereas vaginal secretions are reported
Fig 1. The lack of catabolite inactivation inC. albicans permits simultaneous assimilation of
alternative carbon sources and glucose. In S. cerevisiae, glucose triggers the rapid ubiquitination and
degradation via the GID complex of enzymes involved in the assimilation of alternative carbon sources
(catabolite inactivation). Consequently, S. cerevisiae displays sequential assimilation of these carbon
sources, only utilizing alternative carbon sources once glucose has been exhausted. In contrast, C. albicans
enzymes involved in the utilization of alternative carbon sources lack ubiquitination sites and hence are not
subject to catabolite inactivation. Consequently, these pathways remain active in C. albicans following
glucose exposure and this yeast displays simultaneous assimilation of alternative carbon sources and
glucose [18].
doi:10.1371/journal.ppat.1005566.g001
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to contain around 28 mM (0.5%) glucose [25, 26]. In contrast, glucose concentrations in the
colon are thought to be vanishingly low. Indeed, the ability to assimilate lactate is essential for
gastrointestinal colonisation by Candida glabrata [27]. Additional studies indicate that the
ability to assimilate alternative carbon sources is important for systemic infection by C. albicans
[28, 29]. For example, PCK1 (gluconeogenesis) and ICL1 (glyoxylate cycle) gene expression is
up-regulated in C. albicans following internalization by macrophages or neutrophils, during
gastrointestinal colonization and during renal infection [21, 25, 30, 31]. Also, inactivation of
PCK1 and ICL1 attenuates C. albicans virulence in mouse models of systemic candidiasis [21,
25]. These studies attest to the importance of alternative carbon assimilation for C. albicans col-
onisation and virulence. Collectively, they raise the question as to whether the metabolic flexi-
bility of C. albicans (i.e. in the context of this study, its ability to assimilate glucose and
alternative carbon sources simultaneously) contributes to the virulence of this pathogenic
yeast.
We address this question here. Our approach has been to impose catabolite inactivation in
C. albicans by genetically re-programming the key glyoxylate cycle enzyme, CaIcl1, for glu-
cose-accelerated ubiquitin-mediated protein degradation. The resultant CaICL1-Ubimutant is
less able to colonize the gastrointestinal tract and to cause systemic infections in mice than wild
type controls. We then extended our studies to clinical isolates of S. cerevisiae. Most of the S.
cerevisiae clinical isolates we examined have acquired the ability to utilise lactate and glucose
simultaneously. Furthermore, when we inactivated glucose-accelerated ubiquitin-mediated
protein degradation in a Crabtree positive S. cerevisiae clinical isolate, by deleting GID8, the
gid8 cells were better able to colonise mice than their isogenic GID8 controls. Taken together,
our data indicate that the flexibility to simultaneously assimilate sugars and alternative carbon
sources contributes to the pathogenicity of yeasts.
Results
Metabolic ubiquitination targets have been rewired across yeast species
Recently we reported that some C. albicans enzymes involved in the assimilation of alternative
carbon sources are retained at relatively high levels after cells are exposed to glucose and that,
unlike S. cerevisiae, C. albicans can continue to utilize lactate or oleate in the presence of glu-
cose [18]. We also demonstrated that CaIcl1 is retained following glucose addition because it
lacks the ubiquitination sites present in its S. cerevisiae orthologue, ScIcl1 [18]. This suggested
that ubiquitination sites in key metabolic enzymes may have been rewired in C. albicans rela-
tive to S. cerevisiae. Therefore, our first step was to examine this in more detail. Our in silico
analyses of ubiquitination sites in key metabolic enzymes were performed using Ubpred [32].
This software correctly predicted the existence or lack of ubiquitination sites in ScIcl1 and
CaIcl1, respectively [18]. We examined gluconeogenic, glycolytic, glyoxylate cycle and fatty
acid β-oxidation enzymes across a selection of species from the Saccharomyces and Candida
complexes (Fig 2). Those in the Saccharomyces complex are Crabtree positive, while those in
the Candida complex are Crabtree negative. The species examined in the Saccharomyces com-
plex included the pathogen C. glabrata, and the Candida complex included the non-pathogenic
yeast Debaryomyces hansenii.
Key central metabolic enzymes displayed clear patterns consistent with the evolutionary
rewiring of ubiquitination sites across yeast species (Icl1, Eno1, and Fox2) (Fig 2). In particular,
high confidence ubiquitination sites were observed in Icl1 for all species examined in the Sac-
charomyces complex, but not for those in the Candida complex. Ubiquitination sites were also
observed in Pck1 for three Crabtree positive species, but only in one Crabtree negative species
examined (Fig 2). Therefore, the existence of ubiquitination sites in Icl1 and Pck1 correlated
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closely with Crabtree classification. This correlation was not observed for Mls1, the second
enzyme specific to the glyoxylate cycle. Mls1 ubiquitination sites were not detected in any of
the species examined (S1 Table in the supplementary information), suggesting that the catabo-
lite inactivation of one essential enzyme in a metabolic pathway might be sufficient to decrease
flux through that pathway following glucose exposure. It should be noted, however, that
Ubpred is unable to predict functional ubiquitination sites with complete accuracy as no sites
were predicted for ScFbp1, an enzyme that is known to undergo ubiquitin-mediated catabolite
inactivation [12, 15, 33]. Ubpred utilizes an experimentally validated training set, but some ubi-
quitination sites may only be revealed following posttranslational modification of target pro-
teins [32]. Nevertheless, additional trends linking evolutionary clade and ubiquitination sites
were observed for glycolytic and fatty acid β-oxidation enzymes (Fig 2). Like the glyoxylate
cycle, glycolysis is essential for virulence, and fatty acid β-oxidation may contribute to systemic
infection [25, 29, 34]. Ubiquitination sites were detected in Eno1 for all of the Crabtree negative
species, but not for any of the Crabtree positive species, and the relationship for Fox2 was
almost as strong. Therefore, despite the limitations of in silico prediction, these observations
strongly support the view that rewiring of ubiquitination targets in central metabolism has
occurred during the evolution of yeast species, and that this rewiring contributes to the man-
agement of carbon assimilation strategies in these species.
We have shown previously that, in response to glucose, C. albicans rapidly degrades a modi-
fied version of CaIcl1 bearing a C-terminal ubiquitination motif [18]. Therefore, while C. albi-
cans and other Candida species have rewired metabolic ubiquitination targets, such as Icl1,
these yeasts still retain the apparatus that mediates glucose-accelerated degradation.
Metabolic flexibility increases C. albicans resistance to phagocytic killing
Previously we suggested that this evolutionary rewiring of central metabolic ubiquitination tar-
gets might contribute to the ability of C. albicans to colonize and cause infection in the mam-
malian host. Therefore, we tested this using a C. albicansmutant in which an artificial
ubiquitination site was added to the carboxy terminus of CaIcl1 (CaIcl1-Ubi) to render it sensi-
tive to glucose-induced degradation. However, the CaIcl1-Ubi strains we constructed previ-
ously had the URA3marker integrated at the ICL1 locus [18], and the chromosomal locus at
which URA3 is integrated is known to influence C. albicans virulence-related phenotypes [35].
Fig 2. Evolutionary rewiring of metabolic ubiquitination targets across yeast species. The
phylogenetic tree of the Candida and Saccharomyces species analysed was generated by aligning ITS
sequences using ClustalW. The in silico prediction of ubiquitination sites was performed using Ubpred (www.
ubpred.org) [32] on the metabolic enzymes listed in S1 Table in the supplementary information: grey, the
presence of at least one high confidence ubiquitination site; red, human pathogen; green, not a human
pathogen; blue, Crabtree positive yeast; yellow, Crabtree negative yeast.
doi:10.1371/journal.ppat.1005566.g002
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Therefore, to carefully examine the virulence-related phenotypes of C. albicans cells expressing
CaIcl1-Ubi, we first reconstructed the mutation in the wild type clinical isolate C. albicans
SC5314 using a NAT1marker [36]. We generated isogenic strains in which the wild type
CaIcl1 or CaIcl1-Ubi proteins are epitope-tagged with Myc3 (S2 Table in the supplementary
information). As controls, we also constructed isogenic wild type (ICL1) and homozygous null
strains (icl1Δ/Δ) in the C. albicans SC5314 genetic background. We then reconfirmed that the
addition of the ubiquitination site caused the CaIcl1-Ubi protein to be destabilized in response
to glucose (Fig 3A), thereby recapitulating our earlier observations [18]. Next, we showed that
glucose-accelerated ubiquitin-mediated degradation of CaIcl1 reduces the ability of C. albicans
cells to assimilate an alternative carbon source in the presence of glucose (Fig 3B). C. albicans
ICL1-Ubi cells grew less well than the isogenic wild type control on lactate media containing
the non-metabolizable glucose analogue, 2-deoxyglucose. The ICL1-Ubi cells and their ICL1
controls grew equally well on lactate containing media (S1 Fig). Also the ICL1-Ubi cells
remained sensitive to allyl alcohol (S2 Fig), which is toxic for cells expressing alcohol dehydro-
genase. These data suggest that other aspects of alternative carbon metabolism had not been
perturbed by ICL1manipulation.
ICL1 is strongly induced in C. albicans cells that have been phagocytosed by macrophages
[25, 28], and the glyoxylate cycle promotes resistance to neutrophil-mediated killing [37].
Therefore, we examined the effects of subjecting CaIcl1 to glucose-accelerated ubiquitin-
mediated degradation upon C. albicans survival in macrophages. First we confirmed that C.
albicans cells lacking the glyoxylate cycle are more susceptible to phagocytic killing by J774.1
macrophages in vitro (Fig 4: compare wild type with icl1Δ/Δ). Then we went on to show that
C. albicans ICL1-Ubi cells are more susceptible to macrophage killing than their isogenic con-
trol (Fig 4).
It was conceivable that the manipulation of ICL1 affected the ultrastructure of the C. albi-
cans cell wall in some indirect way, and hence phagocytic recognition [38]. Therefore, we
compared the cell walls of ICL1 and ICL1-Ubi cells by transmission electron microscopy. No
significant differences were observed (S3 Fig). We conclude that imposing catabolite inactiva-
tion upon CaIcl1 renders C. albicans cells less able to survive following phagocytosis. This sug-
gests that the metabolic flexibility to simultaneously exploit alternative carbon sources and
sugars helps C. albicans cells resist phagocytic killing.
Metabolic flexibility promotes C. albicans colonization and virulence
We then tested whether imposing catabolite inactivation upon the glyoxylate cycle affects the
ability of C. albicans to colonize the gastrointestinal tract. To do this, we performed direct com-
petition assays between C. albicans ICL1-Ubi cells and their isogenic control in a murine model
of C. albicans gastrointestinal colonization. Colonisation was assayed by quantifying C. albi-
cans colony forming units (CFUs) in the faeces of mice infected orally with the two competing
strains. The CFUs were significantly reduced for ICL1-Ubi cells (Fig 5A), and the fungal burden
in the caecum was also decreased significantly (Fig 5B). We also compared isogenic wild type
and icl1Δ/Δ cells directly in this model. The icl1Δ/Δmutant was significantly out-competed by
wild type SC5314 cells in the caecum and stool (Fig 5A and 5B). These data indicate that the
glyoxylate cycle plays an important role in gastrointestinal colonization. Furthermore, they
indicate that the imposition of catabolite inactivation on the glyoxylate cycle reduces the fitness
of C. albicans in the gastrointestinal tract.
We also tested whether the C. albicansmutants are capable of dissemination to the kidney.
For all of the strains, some degree of dissemination from the gastrointestinal tract to the
kidney was observed in a subset of colonized mice (Fig 5C). However, this dissemination was
Metabolic Flexibility Promotes Fungal Pathogenicity
PLOS Pathogens | DOI:10.1371/journal.ppat.1005566 April 13, 2016 6 / 26
significantly decreased for the ICL1-Ubi strain and for the icl1Δ/Δ null mutant. The number of
animals in which dissemination was observed was lower for these strains than their isogenic
controls. Furthermore, the fungal burden in the kidneys of these animals was significantly
reduced (Fig 5C). Therefore, a lack of catabolite inactivation of the glyoxylate cycle in C. albi-
cans promotes fungal dissemination in the host.
We then examined the virulence of C. albicans ICL1-Ubi and icl1Δ/Δ cells in a mouse model
of disseminated candidiasis. Compared with their isogenic controls, both mutants displayed
significant reductions in kidney fungal burden (Fig 6A). These strains also showed correspond-
ing decreases in virulence according to their Outcome Score (Fig 6B), which considers mouse
weight change as well as renal fungal burden [39]. These data reconfirm earlier reports that
deletion of CaICL1 reduces the virulence for C. albicans [25, 28]. Furthermore, our data extend
this by showing that the loss of the CaIcl1 enzyme following glucose exposure reduces the viru-
lence of C. albicans during systemic candidiasis. Clearly, CaIcl1 regulation is important for vir-
ulence. Taken together, the evidence suggests that the increased metabolic flexibility afforded
by the evolutionary rewiring of ubiquitination targets in central metabolism promotes C. albi-
cans colonization and infection.
Fig 3. The addition of a ubiquitination site to Icl1 confersC. albicanswith Crabtree positive-like
properties. (A) Western blot demonstrating that the addition of a ubiquitination site to a Myc3-tagged CaIcl1
protein leads to its destabilization following glucose exposure in theC. albicans clinical isolate SC5314.
Similar data were obtained in two independent replicate experiments. (B) Resistance of C. albicans strains to
2-deoxyglucose (2DG) when growing on lactate (Lac) or glucose (Glu). Cultures were replicated onto Glu and
Glu + 2DG (growth examined at 2 days), Lac (growth at 4 days), and Lac + 2DG (growth at 7 days): WT,
SC5314; icl1Δ/Δ, DCY65, ICL1, DCY75 (ICL1-Myc3-NAT1); ICL1-Ubi, DCY82 (ICL1-UbiMyc3-NAT1) (S2
Table in the supplementary information).
doi:10.1371/journal.ppat.1005566.g003
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S. cerevisiae clinical isolates can acquire metabolic flexibility
We asked whether this general principle might be applicable to other yeasts. S. cerevisiae is not
classically considered a pathogen, but infections can occur in severely immunocompromised
patients [40]. While laboratory strains of S. cerevisiae display catabolite inactivation [17] and
are unable to assimilate alternative carbon sources simultaneously with glucose [18], we won-
dered whether S. cerevisiae strains associated with infection have acquired a greater degree of
metabolic flexibility. Therefore, we examined S. cerevisiae clinical isolates from a range of infec-
tion sites including blood, oral cavity, vagina and faeces.
First, we confirmed the identity of putative S. cerevisiae clinical isolates via their proteomic
fingerprints by MALDI-biotyping. Twenty-one of the isolates examined were confirmed to be
S. cerevisiae. Seven proved to be C. glabrata, Candida krusei or Candida lusitaniae (S3 Table in
the supplementary information). The 2-deoxyglucose resistance of the bona fide S. cerevisiae
clinical isolates was then tested. The glucose analogue 2-deoxyglucose is non-metabolizable,
but it activates carbon catabolite repression, thereby preventing the growth of Crabtree positive
yeasts on alternative carbon sources. Strikingly, more than half of the isolates tested were
2-deoxyglucose resistant (62%: 13 of 21 strains), and hence had acquired the ability to assimi-
late lactate in the presence of glucose (Fig 7 and S3 Table in the supplementary information).
As a control we also assayed their allyl alcohol sensitivity. All isolates were sensitive, confirm-
ing that they all expressed alcohol dehydrogenase (S4 Fig). The 2-deoxyglucose resistant phe-
notype did not correlate with the site of isolation (bloodstream, oral, vaginal). Nevertheless, the
observation that many clinical isolates have acquired 2-deoxyglucose resistance is consistent
with the idea that metabolic flexibility promotes host colonisation and hence virulence.
Remodelling S. cerevisiae into a Crabtree negative-like yeast
To further test whether metabolic flexibility promotes S. cerevisiae virulence we generated mutants
in which ubiquitin-mediated catabolite mechanisms were inactivated. Glucose-accelerated protein
Fig 4. Metabolic flexibility inC. albicans promotes resistance to macrophage killing. Survival of C.
albicans strains following co-incubation with J774.1 macrophages for 48 h: WT, SC5314; icl1Δ/Δ, DCY65;
ICL1, DCY75 (ICL1-Myc3-NAT1); ICL1-Ubi, DCY82 (ICL1-Ubi-Myc3-NAT1) (S2 Table in the supplementary
information). Data represent three independent biological experiments performed in technical triplicate (mean
values plus standard error of the mean (SEM)). The data were analysed using one-way ANOVA with Tukey’s
post-hoc test: *, P 0.05; **, P 0.01; ***, P 0.001.
doi:10.1371/journal.ppat.1005566.g004
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Fig 5. Metabolic flexibility inC. albicans enhances gastrointestinal colonization. Pairs of NAT1-marked
C. albicans strains were introduced into mice by oral gavage and fungal burdens (CFUs) for the
nourseothricin resistant and sensitive strains determined in the faeces (A), caecum (B) and kidneys (C) after
14 days. The analysed strains were: WT, SC5314 or DCY95; icl1Δ/Δ, DCY65 or DCY152; ICL1, DCY75 or
Metabolic Flexibility Promotes Fungal Pathogenicity
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degradation in S. cerevisiae is mediated by the vacuolar degradation pathway, which operates in
conjunction with the GID complex [12–14]. Thus, we identified the GID complex components
that are essential for catabolite inactivation by plating S. cerevisiaemutants on lactate medium
containing 2-deoxyglucose (Fig 8A). Wild-type S288c cells were unable to grow on lactate in the
presence of 2-deoxyglucose. Similarly, ubc8 cells, which lack Ubc8 (an ubiquitin-conjugating
enzyme that down-regulates gluconeogenic enzymes), did not grow on lactate plates containing
DCY143 (ICL1-Myc3NAT1); ICL1-Ubi, DCY82 or DCY144 (ICL1-Ubi-Myc3-NAT1) (S2 Table in the
supplementary information). Strains were used in four competition assays: wild-type (NAT1) vs. icl1Δ/Δ
(n = 5); wild-type vs. icl1Δ/Δ (NAT1) (n = 6); ICL1-Myc3 (NAT1) vs. ICL1-Ubi-Myc3 (n = 7); and ICL1-Myc3 vs.
ICL1-Ubi-Myc3 (NAT1) (n = 7). Similar data were obtained in an independent replicate experiment. Points
represent individual animals and the bar denotes the group mean. Data were analyzed by the Mann-Whitney
test using Prism 5: *, P 0.05; **, P 0.01.
doi:10.1371/journal.ppat.1005566.g005
Fig 6. Metabolic flexibility inC. albicans promotes systemic infection. BALB/c mice were injected via
lateral tail vein with the followingC. albicans strains (n = 12 per group): WT, SC5314; icl1Δ/Δ, DCY65; ICL1,
DCY75 (ICL1-Myc3-NAT1); ICL1-Ubi, DCY82 (ICL1-UbiMyc3-NAT1) (S2 Table in the supplementary
information). (A) Renal fungal burdens after 72 h. Points indicate CFUs recovered from each animal and the
bar denotes the mean. (B) Infection outcome scores measured after 72 h using the renal fungal burden
combined with the percentage weight change for the mice ± SEM [39]. Statistical analyses were done by the
Mann-Whitney U test using Prism 5: *, P0.05; **, P 0.01; ***, P 0.001.
doi:10.1371/journal.ppat.1005566.g006
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2-deoxyglucose (Fig 8A). This might be due to functional redundancies with other ubiquitin-con-
jugating enzymes such as Ubc1, Ubc4 and Ubc5. However, S. cerevisiaemutants with defects in
key components of the GID complex (Gid8, Rmd5, Vid30) were able to assimilate lactate in the
presence of 2deoxyglucose. This is consistent with the idea that these GID complex mutants are
defective in catabolite inactivation.
To test this further, we examined the stability of ScIcl1 in wild-type and gid8Δ cells. To
monitor ScIcl1 levels, we epitope tagged this enzyme with Myc9 at its carboxy terminus. As
expected [11, 18], the ScIcl1-Myc9 protein was detected in S. cerevisiae cells grown on lactate,
and was degraded in wild-type S. cerevisiae cells after exposure to glucose (Fig 8B). However,
the ScIcl1-Myc9 protein was stable in gid8Δ cells following glucose addition. The gid8Δ cells
remained sensitive to allyl alcohol (S5 Fig), suggesting that other enzymes involved in alterna-
tive carbon metabolism, and alcohol dehydrogenase in particular, retained their activity follow-
ing GID8 inactivation. These data reinforce the conclusion that an active GID complex is
required for catabolite inactivation. Essentially, Gid8 inactivation converts S. cerevisiae into a
Crabtree negative-like organism that is able to assimilate lactate and glucose simultaneously,
much like C. albicans.
Fig 7. Many S. cerevisiae clinical isolates are Crabtree negative. S. cerevisiae clinical isolates were pre-
grown in YNB-lactate and spotted on SCmedium with glucose or lactate in the presence or absence of
200 μg/mL 2-deoxyglucose. Nine clinical isolates are presented here, with data for a further 12 isolates
presented in S4 Fig in the supplementary information.
doi:10.1371/journal.ppat.1005566.g007
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Flexible carbon utilization protects against macrophage killing and
promotes virulence
Rendering CaIcl1 susceptible to catabolite inactivation makes C. albicans cells more sensitive
to phagocytic killing (Fig 4). Therefore, we predicted that inhibiting catabolite inactivation in
S. cerevisiae would render this yeast more resistant to macrophage killing. We further predicted
that this effect might be observed for S. cerevisiae cells pre-grown on lactate, but not in cells
grown on glucose, effectively priming the cells for metabolic flexibility. This is because gluco-
neogenic and glyoxylate cycle enzymes are induced in lactate-grown cells, irrespective of their
Crabtree status. However, following exposure to the 0.45% glucose in macrophage medium
(DMEM), Crabtree positive cells were expected to rapidly degrade gluconeogenic and glyoxy-
late cycle enzymes via catabolite inactivation, whereas Crabtree negative cells were expected to
retain these enzymes. Therefore, to test the impact of catabolite inactivation on macrophage
killing, we grew Crabtree positive wild-type cells and Crabtree negative-like gid8Δ cells on lac-
tate, and then exposed them to the J774.1 macrophages in DMEM. The same S. cerevisiae iso-
lates were grown on glucose as a control, because gluconeogenic and glyoxylate cycle gene
Fig 8. Inactivation of the GID complex in S. cerevisiae inhibits catabolite inactivation. (A) S. cerevisiae
strains were pre-grown in YNB-lactate and spotted on SCmedium with glucose (Glu) or lactate (Lac) in the
presence or absence of 2-deoxyglucose (2DG): WT, DCY33; rmd5Δ, DCY34; ubc8Δ, DCY35; gid8Δ,
DCY36; vid24Δ, DCY37 (S2 Table in the supplementary information). (B) Western blot of wild-type (DCY134)
and gid8Δ cells (DCY130) expressing ScIcl1-Myc9. Cells were pre-grown in YNB-lactate, exposed to
glucose, and protein extracts prepared at the indicated times. Protein extracts were subjected to western
blotting, and the samemembranes probed for the Myc9 epitope and then for actin as an internal loading
control. Similar data were obtained in two independent replicate experiments.
doi:10.1371/journal.ppat.1005566.g008
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expression is strongly repressed in glucose-grown cells irrespective of their Crabtree status.
Therefore no difference between Crabtree positive and negative cells with respect to gluconeo-
genic and glyoxylate cycle gene expression was expected under glucose conditions, and none
was observed (Fig 9A). In contrast, lactate-grown Crabtree negative-like gid8Δ cells were over
three-fold more resistant to macrophage killing than lactate-grown wild-type control cells (Fig
9A). We conclude that the increased metabolic flexibility, afforded by the loss of Gid8 and
catabolite inactivation, promotes resistance to macrophage killing in S. cerevisiae.
If increased metabolic flexibility enhances resistance to macrophage killing, one might pre-
dict that Crabtree negative-like S. cerevisiae isolates should display relatively high levels of resis-
tance to macrophage killing. To test this, we compared the resistance of three 2deoxyglucose
resistant (Crabtree negative-like) and three 2-deoxyglucose sensitive (Crabtree positive) S. cere-
visiae clinical isolates to macrophage killing (Fig 9B and S3 Table in the supplementary informa-
tion). Control cells that were pre-grown on glucose displayed no major differences in
macrophage resistance. Also, the 2-deoxyglucose resistant and sensitive strains were not signifi-
cantly different when pre-grown on glucose. When pre-grown on lactate, the macrophage resis-
tance of the 2-deoxyglucose sensitive isolates did not increase compared to pre-growth on
glucose. This was consistent with the idea that in these Crabtree positive strains, gluconeogenic
and glyoxylate cycle enzymes are rapidly degraded following glucose exposure (i.e. transfer to
DMEM). Indeed, the isocitrate lyase activity decreased rapidly in most of the Crabtree positive
strains examined (Fig 9C). In contrast, growth on lactate increased the macrophage resistance of
all three of the 2-deoxyglucose resistant strains. For strain J960965 the circa four-fold increase
was not statistically significant, but for strains J941047 and J940610, the lactate-induced
increases were highly significant relative to control cells pre-grown on glucose (Fig 9B).
It was conceivable that the resistance of the Crabtree negative S. cerevisiae isolates to macro-
phage killing was due to reduced phagocytic uptake rather than increased survival following
phagocytosis. Therefore, we compared the uptake of the Crabtree positive and negative S. cere-
visiae clinical isolates by the J774.1 macrophages. No significant differences were observed (Fig
9D). Therefore, increased metabolic flexibility appears to enhance resistance to macrophage
killing.
We reasoned that elevated macrophage resistance might be reflected in increased virulence,
and therefore we tested the impact of GID8 inactivation upon virulence. First, the GID8 gene
was deleted in the Crabtree positive S. cerevisiae clinical isolate NCPF8313 to generate a gid8
null mutant, and then the GID8 gene was reintroduced to generate the gid8+GID8 control
strain. The loss of GID8 in this clinical isolate permitted lactate assimilation in the presence of
glucose (Fig 10A), essentially converting this strain into a Crabtree negative-like yeast. The
same phenotype was observed when GID8 was deleted in S. cerevisiae S288c (S5 Fig in the sup-
plementary information). GID8 reintegration then restored Crabtree positivity (Fig 10A), con-
firming that Gid8 is essential for catabolite inactivation in S. cerevisiae clinical isolates.
The virulence of the isogenic NCPF8313 strain set was then tested in DBA/2 mice, since
complement factor 5-deficient mice are susceptible to S. cerevisiae infection [41]. The deletion
of GID8 led to a statistically significant increase in kidney fungal burden in this immunocom-
promised background, the effect being lost following GID8 reintegration. Taken together, the
data indicate that the metabolic flexibility to simultaneously assimilate alternative carbon
sources and glucose enhances virulence in S. cerevisiae.
Discussion
Yeast pathogenicity is a polygenic trait. A range of virulence factors contribute to pathogenic-
ity, including yeast-hypha morphogenesis, adhesins and invasins, and secreted hydrolases [42].
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Fig 9. Crabtree negative S. cerevisiae strains are more resistant to macrophage killing. (A) S. cerevisiaewild-type (black bars, S288c) and gid8Δ cells
(red, DCY122) were pre-grown in YNB-glucose or YNB-lactate, and then co-incubated with J774.1 macrophages. The viability of the gid8Δ cells after 48
hours is expressed relative to the corresponding wild type control. (B) Using the same approach, the resistance of three Crabtree positive S. cerevisiae
clinical isolates (black) and three Crabtree negative clinical isolates (red) to macrophage killing was compared. (C) Isocitrate lyase activities were measured
in the same S. cerevisiae strains after pre-growth overnight in YNB-lactate followed by growth in YNB-glucose or YNB-lactate for 2 h. The fold-reduction in
Icl1 activity in cells exposed to glucose is expressed relative to the control cells grown in lactate. Statistical significance was calculated relative to the fold-
reduction observed in the wild type control (S288c). (D) The phagocytic uptake of the S. cerevisiae strains was determined after pre-growth in YNB-lactate,
and then co-incubation with J774.1 macrophages for 2 h. No significant differences (ns) were observed relative to the wild type control. The data represent
two independent biological experiments performed in technical triplicate ± SEM. They were analysed relative to the glucose grown controls by two-way
ANOVA with multiple comparisons test: *, P 0.05; **, P 0.01; ***, P 0.001; ****, P 0.0001.
doi:10.1371/journal.ppat.1005566.g009
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Fig 10. A Crabtree negative S. cerevisiae strain is more virulent in immunocompromisedmice. (A)
Inactivation ofGID8 in S. cerevisiae clinical isolate NCPF8313 renders it 2-deoxyglucose resistant. S.
cerevisiae strains were pre-grown in YNB-lactate and spotted on SCmedium with glucose (Glu) or lactate
(Lac) in the presence or absence of 2-deoxyglucose (2DG): WT, DCY145; gid8Δ, DCY150; gid8Δ+GID8,
DCY148 (S2 Table in the supplementary information). (B) Immunodeficient DBA/2 mice were injected via
lateral tail vein with the same S. cerevisiae strains and renal fungal burdens were measured after 72 h (n = 6
per group). Points represent the CFUs for each animal and the bar denotes the mean. (C) The infection
outcome scores were then determined by combining the renal fungal burdens with the percentage weight
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Pathogenicity is also enhanced by fitness attributes such as robust stress responses and effi-
cient metabolic adaptation [43–45]. Clearly the ability to assimilate the variety of carbon
sources available in host niches is advantageous to pathogenic yeasts. For example, the loss of
glycolysis or glucose sensing attenuates the dissemination and pathogenicity of the basidiomy-
cete yeast Cryptococcus neoformans [46]. Also, mutations that block glycolysis, gluconeogene-
sis or the glyoxylate cycle attenuate the virulence of C. albicans, an ascomycete yeast [25, 28,
29]. We now show that the coordinated regulation of these pathways is important for viru-
lence in C. albicans and S. cerevisiae. Our data suggest that evolutionary pressures in host
niches have selected for yeasts with enhanced metabolic flexibility that permits the simulta-
neous exploitation of sugars and alternative carbon sources. This view is supported by several
key observations.
Firstly, there appears to have been evolutionary rewiring of central metabolic ubiquitination
targets in the ascomycete yeasts (Fig 2). Yeasts in the Saccharomyces clade tend to contain ubi-
quitination sites in glyoxylate cycle (Icl1) and gluconeogenic enzymes (Pck1), whereas species
in the Candida clade generally carry ubiquitination sites in glycolytic (Eno1) and fatty acid β-
oxidation enzymes (Fox2). The introduction of such a site in CaIcl1 is sufficient to promote
glucose-accelerated ubiquitin-mediated degradation of this enzyme (Fig 3). Not all enzymes on
these pathways are predicted to carry an ubiquitination site. However, the loss of one essential
enzyme on a metabolic pathway is sufficient to inhibit flux through that pathway.
Secondly, although S. cerevisiae is classified as a Crabtree positive yeast, many clinical iso-
lates have acquired the flexibility to simultaneously assimilate alternative carbon sources along-
side glucose (Fig 7, and S4 Fig and S3 Table in the supplementary data). However, not all
clinical isolates have become Crabtree negative. Also, the pathogen C. glabrata, which is a
member of the Saccharomyces clade, is Crabtree positive. However, S. cerevisiae and C. glabrata
are less potent pathogens than C. albicans [40, 47]. Taken together, these observations are con-
sistent with the view that metabolic flexibility is one of a number of factors that contribute to
the pathogenicity of yeast species.
Thirdly, this view is reinforced by the observation that reducing the metabolic flexibility of
C. albicans attenuates its ability to colonize and cause infection. The addition of a ubiquitina-
tion site to CaIcl1 triggered its degradation in response to glucose, thereby reducing the ability
of C. albicans cells to assimilate lactate and glucose simultaneously (Fig 3) [18]. This mutation
essentially shifted C. albicans towards a Crabtree positive-like state. It rendered C. albicans
more sensitive to macrophage killing (Fig 4), reduced its ability to colonise the gastrointestinal
tract (Fig 5), and attenuated its ability to cause systemic infection in immunocompetent mice
(Fig 6).
Fourthly, we show that the virulence of a S. cerevisiae clinical isolate correlates with its meta-
bolic flexibility. The deletion of a key GID complex component (Gid8) inhibited catabolite
inactivation in a Crabtree positive S. cerevisiae clinical isolate (Fig 8), thereby converting it into
a Crabtree negative-like strain that is now able to assimilate lactate and glucose simultaneously
(Fig 8). Even though gid8mutations reduce biofilm formation, ethanol resistance and thermo-
tolerance in S. cerevisiae, the inactivation of GID8 increased the resistance of S. cerevisiae to
macrophage killing (Fig 9A) and increased the virulence of this yeast in the immunocompro-
mised host (Fig 10). This was consistent with the observation that Crabtree negative S. cerevi-
siae clinical isolates are more resistant to macrophage killing than Crabtree positive isolates
(Fig 9B).
change for the mice ± SEM [39]. The data were analysed using the MannWhitney test: *, P 0.05; **,
P 0.01.
doi:10.1371/journal.ppat.1005566.g010
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Our observations reinforce previous reports describing the importance of the glyoxylate
cycle and alternative carbon metabolism for microbial infection.Mycobacterium tuberculosis
mutants that lack the glyoxylate cycle display attenuated virulence [25, 28, 48]. This is also the
case for C. albicans icl1mutants, which are less pathogenic in the murine model of systemic
candidiasis [1, 24, 25, 28]. Our data extend this by showing that the glyoxylate cycle promotes
gastrointestinal colonization and the dissemination of C. albicans to the kidney. This supports
the idea that isocitrate lyase represents a potential target for therapeutic intervention [49, 50]
as the glyoxylate cycle is not conserved in mammalian cells.
Our findings also highlight the importance of posttranscriptional regulation in metabolic
control. C. albicans has retained the same tight transcriptional repression of glyoxylate cycle
genes and other genes required for the assimilation of alternative carbon sources that is
observed in S. cerevisiae in response to glucose. For example, in both C. albicans and S. cerevi-
siae, ICL1 and PCK1 transcript levels decrease dramatically following glucose exposure [18, 21,
22]. Yet C. albicans continues to assimilate alternative carbon sources in the presence of glu-
cose, whereas S. cerevisiae does not [18]. This is because key central metabolic enzymes are sub-
ject to ubiquitination and degradation (catabolite inactivation) in S. cerevisiae, but not in C.
albicans [18]. This implies that catabolite inactivation, rather than carbon catabolite repression,
plays the major role in controlling the short term management of carbon assimilation.
The impact of Crabtree effects on growth in complex microenvironments is likely to be sub-
tle. For example, we would expect isogenic Crabtree positive and negative strains to grow at
similar rates during protracted exposure to sugars or alternative carbon sources, as they would
be expected to express similar levels of glycolytic enzymes during growth on sugars, and similar
levels of gluconeogenic enzymes during growth on alternative carbon sources. Crabtree posi-
tive and negative strains are only likely to behave differently during transitions between alter-
native carbon sources to sugars. Following transient exposure to glucose, Crabtree positive
strains degrade their gluconeogenic enzymes and must resynthesize these enzymes to resume
growth on the alternative carbon sources. In contrast, Crabtree negative strains retain these
enzymes and therefore are able to resume growth on the alternative carbon sources once the
glucose is exhausted. Therefore, when the two are compared directly, a subtle phenotype is
expected, where Crabtree negative cells display more continuous growth than Crabtree positive
cells during transitions between alternative carbon sources to sugars. When we tested this, we
did not detect significant differences between C. albicans ICL1 and ICL1-Ubi cells in competi-
tion experiments with NAT1-marked strains in vitro on defined lactate-containing media with
various frequencies of glucose addition. We reason that the degree of competition must depend
on the frequency of glucose exposure relative to cell doubling times and enzyme clearance
rates. Whatever the basis for this, our in vitro experiments failed to capture the complexity of
in vivo niches where competition was reproducibly observed. Nevertheless, experimental
observations suggest that the relaxation of the transcriptional control mediated by carbon
catabolite repression can enhance the ability of S. cerevisiae cells to compete in vitro depending
on the frequency and duration of changes in carbon source [51]. This represents a trade-off
between the costly expression of enzymes required for growth on alternative carbon sources
and the speed with which metabolism can be reprogrammed to assimilate these alternative car-
bon sources when sugars become limiting. Our work suggests that the advantages of “flexible”
over “specialist” carbon utilization strategies [51] extend to fungal pathogens as they colonise
complex host niches.
The simultaneous assimilation of glucose and alternative carbon sources raises interesting
questions about metabolic fluxes. Formally, glycolysis and gluconeogenesis are not expected to
occur in the same cell because this might be predicted to set up futile cycles at the Pfk-Fba and
Pyk-Pck steps. However, futile cycling appears to be minimal in S. cerevisiae cells expressing
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gluconeogenic enzymes during growth on glucose [52]. Therefore, it is conceivable that when
C. albicans cells are assimilating both glucose and lactate for example, much of the carbon
from the glucose is used for cell wall construction and flows down the glycolytic pathway,
whilst much of the carbon from the lactate flows into the glyoxylate and TCA cycles. This
remains to be tested.
In conclusion, on the basis of our observations in evolutionarily divergent yeasts, we suggest
that catabolite inactivation of central anabolic pathways is disadvantageous to yeasts during
interactions with the mammalian host. This reflects the complexity of host niches, which are
often poor in glucose, but rich in alternative carbon sources. The re-synthesis of enzymes
required for alternative carbon utilization following transient exposure to glucose is likely to be
energetically demanding, possibly providing a competitive disadvantage against other organ-
isms in the gut microbiota, for example. In contrast, catabolite inactivation might be advanta-
geous to saprobic yeasts that occupy environmental niches. Consequently, some pathogenic
yeasts of environmental origin, such as Cryptococcus neoformans andHistoplasma capsulatum,
may have retained catabolite inactivation [53]. If so, given the contrasting nutrient availabilities
in divergent host niches, we speculate that catabolite inactivation might influence the tissue
tropism of such infections.
Materials and Methods
Strains and growth conditions
C. albicans and S. cerevisiae strains (S2 and S3 Tables in the supplementary information) were
routinely grown at 30°C in minimal medium (0.67% yeast nitrogen base without amino acids)
containing 2% glucose or 2% lactate as the sole carbon source. Auxotrophic S. cerevisiae
strains were provided with appropriate supplements (10 μg/mL). Nourseothricin resistant C.
albicans colonies carrying the NAT1marker were selected on YPD plates [54] containing
200 μg/mL nourseothricin (Werner Bioagents, Jena, Germany). To facilitate NAT1marker
recycling, C. albicans strains were grown overnight in YCB-BSA medium (23.4 g yeast carbon
base, 4 g bovine serum albumin) at 30°C and plated on YPD with 25 μg/mL nourseothricin.
For S. cerevisiae NAT1marker recycling, cells were grown for 6 h in YP-Gal (1% yeast extract,
2% peptone, 2% galactose) at 30°C and plated on YPD plates. S. cerevisiae sensitivity to nour-
seothricin was confirmed by patching colonies onto YPD plates with and without 100 μg/mL
nourseothricin.
To test 2-deoxyglucose sensitivity, yeast strains were grown overnight in SC-lactate, har-
vested, washed with sterile PBS, counted by haemocytometer, and 5x104 cells spotted on freshly
prepared SC agar containing 2-deoxyglucose (Sigma, Dorset, UK) at 200 μg/mL for S. cerevisiae
[55] and 40 mg/mL for C. albicans [56]. Plates were incubated at 30°C for 24 h and imaged.
To test allyl alcohol sensitivity, yeast strains were prepared as described above for 2deoxy-
glucose sensitivity testing, but spotted onto freshly prepared YNB agar containing 2% glycerol
with or without 20 mM allyl alcohol. Plates were imaged after incubation at 30°C for 3 days.
Strain construction
C. albicans strains expressing ICL1-MYC3 or ICL1-Ubi-MYC3 were constructed as follows. The
3’-terminal region of ICL1-MYC3 was PCR amplified from strain CA1395 [18] and cloned into
the NAT1-FLP plasmid using KpnI and ApaI [36]. ICL1-Ubi-MYC3 was constructed via over-
lap extension PCR using strains CA1395 and DSCO4 as genomic templates, and the resulting
PCR product cloned into NAT1-FLP using KpnI and ApaI. Next, the ICL1 terminator sequence
was PCR amplified and cloned into ICL1-MYC3-NAT1-FLP and ICL1-Ubi-MYC3NAT1-FLP
using NotI and SacII. The resultant ICL1-MYC3 and ICL1-Ubi-MYC3 NAT1-FLP integration
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cassettes were then PCR amplified and transformed into C. albicans SC5314. Following NAT1-
FLP excision, the process was repeated to replace the second ICL1 allele with either ICL1-MYC3
or ICL1-Ubi-MYC3 NAT1-FLP. The NAT1-FLP cassette was then excised to generate strains
DCY75 and DCY82, respectively. Integration events and NAT1FLP excision were confirmed
by diagnostic PCR.
To reconstruct the icl1Δ/Δmutation in the C. albicans SC5314 background, sequences
upstream and downstream of the ICL1 open reading frame were PCR amplified and cloned
into the NAT1-FLP plasmid using KpnI/ApaI and NotI/SacII, respectively. The icl1Δ cassette
was then PCR amplified and transformed into C. albicans SC5314. After NAT1-FLP excision, a
second round of transformation was performed with the icl1Δ cassette to disrupt the remaining
wild-type ICL1 allele and generate the strain DCY65. Deletion of ICL1 and NAT1-FLP excision
were confirmed by diagnostic PCR.
NAT1 barcoded strains were constructed for in vivo competition experiments by integrating
StuI-linearized pBC1 at the C. albicans RPS1 locus in strains DCY65, DCY75, and DCY82.
pBC1 integration at RPS1 was confirmed by diagnostic PCR.
The S. cerevisiae gid8Δ/Δ strains were constructed by PCR amplification of the loxPNA-
T1-loxP cassette from plasmid pUG74 [57] using oligonucleotide primers with homology to
regions immediately upstream and downstream of ScGID8. The ScGID8 deletion cassette was
transformed into S288c and NCPF8313. Following disruption of one allele of ScGID8, inte-
grants were transformed with plasmid pSH69 [57] and cre expression induced to recycle the
NAT1marker. To delete the second ScGID8 allele in NCPF8313, a second ScGID8 disruption
cassette was PCR amplified from pUG74 with primers homologous to ScGID8 sequences that
lie inside the region deleted in the first Scgid8::loxP allele. Cassette integration, ScGID8 deletion
and NAT1 excision were confirmed by diagnostic PCR. To generate a control strain with
ScGID8 reintegrated for in vivo experiments, the ScGID8 locus was PCR amplified and cloned
into plasmid pRS303N [58] using PacI and AscI. The HIS3NAT1-GID8-HIS3 cassette was PCR
amplified and transformed into DCY124, resulting in strain DCY148. The control strains
DCY145 and DCY150 were constructed by PCR amplifying the empty HIS3-NAT1-HIS3 cas-
sette from pRS303N and transforming this cassette into NCPF8313 and DCY124, respectively.
Integration at the ScHIS3 locus was confirmed by diagnostic PCR.
S. cerevisiae strains expressing ScICL1-MYC9 were constructed by PCR amplifying the
MYC9-NAT1 cassette from plasmid pYM21 [59] using primers with sequences homologous to
the 3’-end of ScICL1. TheMYC9-NAT1 cassette was transformed into wild-type S. cerevisiae
S288c. Integration ofMYC9-NAT1 at the ScICL1 locus was confirmed by diagnostic PCR and
western blotting of ScIcl1-Myc9.
In silico analysis of ubiquitination sites
The amino acid sequences of the enzymes listed in Fig 1 and S1 Table in the supplementary
data were submitted to UbPred (www.ubpred.org) for ubiquitination site prediction [32].
Enzymes that returned at least one high confidence site score (>0.84) were considered high
probability targets for ubiquitination.
Western blotting
Protein extracts were prepared from C. albicans and S. cerevisiae cells using previously described
protocols [60], and then subjected to western blotting as described [61]. Total protein extracts
(15 μg) were separated on 4–12% NuPage gels (Life Technologies, Bleiswijk, Netherlands) and
transferred to PVDF membranes. Membranes were blocked with 5%milk in 1x PBS with 0.01%
Tween-20, then incubated with primary anti-Myc (Cell Signalling Technology #2272; Danvers,
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MA, USA) or anti-actin antibodies (Sigma #A5060; Dorset, UK) overnight at 4°C with shaking.
Membranes were repeatedly washed in PBS containing 0.01% Tween-20, incubated with sec-
ondary HRP-conjugated goat anti-rabbit antibody (Cell Signalling, Danvers, MA, USA), and
signals detected using the ECL system (GE Amersham; Little Chalfont, UK).
Isocitrate lyase activity assay
Yeast cells were harvested by centrifugation at 4°C, washed, and suspended in 0.25 ml of 10
mMMOPS, pH 7.3 with Protease Inhibitor Cocktail (Sigma, Dorset, UK) and an equal volume
of glass beads (Sigma, Dorset, UK). Cells were lysed at 4°C using a FastPrep system (Thermo
Savant, Middlesex, UK), and centrifuged for 10 min at 10,000 rpm at 4°C. Isocitrate lyase activ-
ities were assayed in the resultant supernatants as described previously [62].
Macrophage assays
An end-point dilution assay was used to determine the survival rates of C. albicans and S. cere-
visiae cells exposed to J774.1 macrophages [63]. Macrophages (1.5 x 105) were incubated over-
night in 150 μL DMEM (Lonza; Slough, UK) containing 10% FBS (Gibco, Life Technologies,
Bleiswijk, Netherlands) in 96 well plates at 37°C under 5% CO2. C. albicans and S. cerevisiae
cells were grown overnight in SC-glucose or SC-lactate, washed twice in sterile PBS, and then
counted by haemocytometer. The yeast cells were resuspended at 107 cells/mL in cold DMEM
containing 10% FBS and kept on ice. The cell suspensions were serially diluted (4-fold) into
wells containing 150 μL of DMEM plus 10% FBS with and without macrophages. Plates were
incubated on ice for 30 minutes, and then at 37°C in 5% CO2 for 48 h. Yeast colonies in each
well were then counted to determine survival in the presence of macrophages, relative to the no
macrophage controls. Results were subjected to statistical analysis by one-way ANOVA with
Tukey’s post-hoc test or two-way ANOVA with multiple comparisons using Prism 5 software:
 P 0.05;  P0.01;  P0.001;  P0.0001.
For the phagocytic uptake assay, yeast strains were grown in YNB-lactate containing amino
acids at 30°C, and J774.1 macrophages were cultured in DMEM, as described above. Yeast cells
were then exposed to macrophages in a ratio of 5:1 (yeast to macrophages), and incubated in
DMEM for 2h at 37°C. Free yeast cells were stained with 5 μg/mL of ConATexas Red (Thermo
Scientific, Cramlington, UK) for 45 min. The macrophages were then lysed with 0.025% SDS
to release the phagocytosed yeast cells, and all yeast cells then were stained with 50 μg/mL Cal-
cofluor White for 30 min, washed, and fixed with 4% formaldehyde. The Calcofluor White
stained yeast cells were analysed by flow cytometry, and the proportion of phagocytosed cells
determined by comparing ConA-Texas Red negative and positive cells. Phagocytotic uptake
was then expressed relative to that observed for the wild type control (S288c).
Gastrointestinal colonization
Competitive colonization assays were performed using female BALB/c mice (6–8 weeks; Har-
lan, UK). The mice were randomly assigned to groups of 6–7 mice, housed in individually ven-
tilated cages, and provided with food ad libitum. To reduce endogenous bacterial and fungal
organisms, mice were placed on sterile water containing 2 mg/mL streptomycin (Invitrogen),
2,000 U/mL penicillin (Invitrogen) and 0.25 mg/mL fluconazole (Discovery Fine Chemicals,
Dorset, UK) for 4 days, and then switched to sterile water containing only streptomycin and
penicillin for 24 h. Mice were gavaged with a total of 2x107 C. albicans: 1x107 cells of each strain
used in each two-way competition assay. Four competition assays were performed: wild-type
(NAT1) vs. icl1Δ/Δ; wild-type vs. icl1Δ/Δ (NAT1); ICL1-Myc3 (NAT1) vs. ICL1-Ubi-Myc3; and
ICL1-Myc3 vs. ICL1-Ubi-Myc3 (NAT1). C. albicans strains were prepared by growing overnight
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in NGY medium (0.1% Neopeptone, 0.4% glucose, 0.1% yeast extract [39]) at 30°C with shak-
ing, and then washing and resuspending them in sterile saline. Cells were counted by haemo-
cytometer and diluted to 1x108 cells per mL for gavage. Following gavage, stools were collected
from individual mice at days 2, 4, and 14 to monitor colonization and mice were monitored
and weighed daily. Faeces were homogenized in 500 μL sterile PBS, serially diluted and plated
on Sabouraud’s Dextrose agar [64] containing 2 μg/mL gentamicin and 5 μg/mL chloramphen-
icol with and without 200 μg/mL nourseothricin to determine the total and NAT1 fungal bur-
dens. On day 14, mice were humanely terminated by cervical dislocation and kidneys and
caecum were aseptically removed. Kidneys and caecum were homogenized in 500 μL sterile
PBS and fungal burdens determined by plating, as described above. Statistical analyses of
the fungal burdens were performed with the Mann-Whitney U test using Prism 5:  P0.05;
 P0.01;  P0.001.
Virulence assays
The 3-day murine intravenous challenge model was used to assay yeast virulence as previously
described [39]. Immunocompetent female BALB/c mice (6–8 weeks; Harlan, UK) were used
to assay the virulence of C. albicans strains. For S. cerevisiae, complement factor 5-deficient
female DBA/2 mice (6–8 weeks; Harlan, UK) were used instead because S. cerevisiae clinical
isolates generally cause minimal disease in immunocompetent mice [41]. The mice were ran-
domly assigned to groups of 6 and housed separately in individually ventilated cages. Food and
water were provided ad libitum. C. albicans was grown overnight in NGY medium at 30°C
with shaking. S. cerevisiae strains were grown overnight in SC-Lactate. Fungal cells were har-
vested, washed, resuspended in sterile saline, and cells were counted. Approximately 1x106
cells were injected into each mouse via the lateral tail vein. The mice were monitored and
weighed daily. At 72 h post-infection, mice were weighed, killed humanely by cervical disloca-
tion, and their kidneys removed aseptically for determination of fungal burdens. Virulence out-
come scores were determined by assessing renal fungal burden and percentage weight change
at 72 h using the formula: outcome score = log (renal CFU g−1) − (0.5 × percentage weight
change) [39]. Statistical analyses were done by the Mann-Whitney U test using Prism 5:
 P0.05;  P0.01;  P0.001.
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condition at least twice per day, and were weighed once per day. Euthanasia was performed
humanely by cervical dislocation when animals showed signs of severe illness (e.g. ruffled coat,
hunched posture, unwillingness to move and 20% loss of initial body weight). During these
studies there were no unexpected deaths. Analgesia and anaesthesia were not employed in this
study.
Supporting Information
S1 Fig. Growth and Isocitrate lyase activities in C. albicans ICL1 strains. (A) Isocitrate lyase
(Icl1) activities were assayed in extracts from mid-exponential C. albicans SC5314 (ICL1/ICL1)
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and DCY65 (icl1Δ/icl1Δ) cells grown on YNB-glucose or YNB-lactate plus amino acids at
30°C. These Icl1 activities reflect Icl1 levels observed by western blotting. (B) Growth of C. albi-
cans DCY75 (ICL1-Myc3/ICL1-Myc3) and DCY82 (ICL1-Ubi-Myc3/ICL1Ubi-Myc3) on YNB-
lactate at 30°C. (C) Growth of the same strains C. albicans DCY75 (ICL1Myc3/ICL1-Myc3) and
DCY82 (ICL1-Ubi-Myc3/ICL1-Ubi-Myc3) on YNB-lactate plus amino acids at 30°C.
(PDF)
S2 Fig. Perturbing ICL1 in C. albicans affects 2-deoxyglucose resistance, but does not affect
allyl alcohol sensitivity. The C. albicans strains presented in Fig 3B were also plated onto
YNB-glycerol (Gly) containing or lacking 20 mM allyl alcohol (AA).
(PDF)
S3 Fig. The addition of an ubiquitination site to Icl1 does not affect cell wall ultrastructure
in C. albicans. The C. albicans strains DCY75 (ICL1-MYC3) and DCY82 (ICL1-UBI-MYC3)
were grown in YNB-lactate at 30°C. Cells were frozen under high pressure, freeze substituted
and embedded in Spurr’s resin as described previously [Hall RA et al. (2013) PLoS Pathogens 9
(4): e1003276]. Ultrathin sections were stained with uranyl acetate and lead citrate and imaged
with a JEM1400 transmission electron microscope (Jeol Ltd.). Images were recorded using an
AMT ActiveVu XR16M camera (Deben UK Ltd.). The scale bar represents 200 nm and is the
same for all panels.
(PDF)
S4 Fig. Some S. cerevisiae clinical isolates are Crabtree negative, but all are sensitive to allyl
alcohol. S. cerevisiae clinical isolates were pre-grown in YNB-lactate and spotted on SC
medium with glucose or lactate in the presence or absence of 200 μg/mL 2DG. They were also
spotted onto YNB-glycerol (Gly) containing or lacking 20 mM allyl alcohol (AA). The clinical
isolates presented in Fig 7 are included in this figure.
(PDF)
S5 Fig. The inactivation of GID8 in S. cerevisiae S288c confers 2-deoxyglucose resistance,
but does not affect its sensitivity to allyl alcohol. S. cerevisiae strains presented in Fig 10A
were also plated onto YNB-glycerol (Gly) containing or lacking 20 mM allyl alcohol (AA).
These data support the observation that GID8 inactivation makes S. cerevisiae 2-deoxyglucose
resistant (Fig 10A), and suggest that it does so without affecting alcohol dehydrogenase.
(PDF)
S1 Table. List of metabolic sequences analysed by UbPred to predict ubiquitination motifs.
(PDF)
S2 Table. Strains used in this study.
(PDF)
S3 Table. 2-Deoxyglucose resistance of Saccharomyces cerevisiae clinical isolates.
(PDF)
S4 Table. Primers used in this study.
(PDF)
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